Michael Offin

Ado-Trastuzumab Emtansine for Patients With <i>HER2</i>-Mutant Lung Cancers: Results From a Phase II Basket Trial

Bob T. Li, Ronglai Shen, Darren J. Buonocore et al. · Journal of Clinical Oncology · 2018 · 541 citations

Tumor Biology, Partial Response Rate, Medicine +14

High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden

Ryma Benayed, Michael Offin, Kerry Mullaney et al. · Clinical Cancer Research · 2019 · 466 citations · Full text

Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes

Michael Offin, Joseph M. Chan, Megan Tenet et al. · Journal of Thoracic Oncology · 2019 · 428 citations · Full text

Tumor Biology, Medicine, Pathology +11

Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer

Joseph M. Chan, Àlvaro Quintanal-Villalonga, Vianne R. Gao et al. · Cancer Cell · 2021 · 396 citations · Full text

Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with <i>EGFR</i> -Mutant Lung Cancers

Michael Offin, Hira Rizvi, Megan Tenet et al. · Clinical Cancer Research · 2018 · 323 citations · Full text